A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 1, 2011, Pages 77-82

  Guerrero, Laura ^a   Pinazo, Ma Jesús ^b   Posada, Elizabeth ^b   Gascón, Joaquim ^b   Ribas, Josep ^a   Soy, Dolors ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Analytics; Benznidazole; Chagas disease; High pressure liquid chromatography; Human plasma; Validation

Indexed keywords

ACETONITRILE; BENZNIDAZOLE; BENZOCAINE; TRICHLOROACETIC ACID; WATER;

ACID PRECIPITATION; ADULT; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INJECTION VOLUME; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; PRIORITY JOURNAL;

ADULT; CHAGAS DISEASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; NITROIMIDAZOLES; REPRODUCIBILITY OF RESULTS; TRYPANOCIDAL AGENTS;

TRYPANOSOMA CRUZI;

EID: 79953159344     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.014     Document Type: Article

References (22)

1. Garcia S, Ramos CO, Serna JF, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, et al. Treatment with benznidazole during the chronic phase of experimental Chagas'disease decrease cardiac alterations. Antimicrob Agents Chemother 2005;49:1521-8. (Pubitemid 40463384)
2. Coura JR, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002;97:3-24. (Pubitemid 135746197)
3. Muñoz J, Coll O, Juncosa T, Vergés M, del pino M, Fumado V, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending two maternity clinics in Barcelona, Spain. Clin Infect Dis 2009;48:1736-40.
4. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010;115:22-7.
5. Piron M, Vergés M, Muñoz J, Casamitjana N, Sanz S, Maymò RM, et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia, Spain. Transfusion 2008;48:1862-8.
6. de Lana M, Lopes LA, Martins HR, Bahia MT, Machado-de-Assis GF, Wendling AP, et al. Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment. Mem Inst Oswaldo Cruz 2009;104:1139-47.
7. Raaflaub J, Ziegler WH. Multiple-dose kinetics of the trypanosomicide benznidazole in man. Drug Res 1979;29:1611-4. (Pubitemid 10231718)
8. Raaflaub J. Multiple-dose kinetics of the trypanosomicide benznidazole in man. Drug Res 1980;30:2192-4. (Pubitemid 11196302)
9. Morilla MJ, Benavidez PE, Lopez MO, Romero EL. Liposomal benznidazole: a high-performance liquid chromatographic determination for biodistribution studies. J Chromatogr Sci 2003;41:405-9.
10. Jehl F, Gallion C, Monteil H. High-performance liquid chromatography of antibiotics. J Chromatogr 1990;531:509-49.
11. Skoog D, Holler FJ, Nieman TA. Principios de Análisis Instrumental, 5th ed. Madrid (Spain): The McGraw- Hill Company; 2001.
12. Meyer V. Practical high-performance liquid chromatography, 4th ed. Switzerland: John Wiley & Sons, Ltd; 2004.
13. Department of Health and Human Services Food and Drug Administration (U.S). URL: a. http://www.fda.gov/cder/guidance/4252fnl.pdf. [Accessed January 12, 2010],
14. Department of Health and Human Services Food and Drug Administration (U.S) b. http://www.fda.gov/cder/guidance/cmc3.pdf. [Accessed January 12, 2010],
15. Department of Health and Human Services Food and Drug Administration (U.S), c. http://www.fda.gov/cber/gdlns/methval.pdf. [Accessed January 12, 2010].
16. The European Agency for the Evaluation of Medicinal Products (Europe). URL: a. http://www.emea.europa.eu/htms/vet/vetguidelines/quality.htm [Accessed January 12, 2010],
17. The European Agency for the Evaluation of Medicinal Products (Europe), b. http://www.emea.europa.eu/pdfs/human/ich/038195en.pdf [Accessed January 12, 2010].
18. Lang JR, Bolton S. A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry. J Pharm Biomed Anal 1991;5:361-75.
19. Christodoulou EA, Samanidou VF, Papadoyannis IN. Validation of an HPLC-UV method according to the European Union Decision 2002/657/EC for the simultaneous determination of 10 quinolones in chicken muscle and egg yolk. J Chromatogr 2007;857:246-55. (Pubitemid 350046460)
20. Samanidou VF, Nisyriou SA, Papadoyannis IN. Development and validation of an HPLC method for the determination of penicillin antibiotics residues in bovine muscle according to the European Union Decision 2002/657/EC. J Sep Sci 2007;30:3193-01.
21. Walton MI, Workman P. Reversed-phase high-performance liquid chromatographic method for the simultaneous determination of the 2-nitroimidazole benznidazole and its amine metabolite in biological materials. J Chromatogr 1986;375:190-6. (Pubitemid 16110056)
22. Workman P, White RA, Walton MI, Owen LN, Twentyman PR. Preclinical pharmacokinetics of benznidazole. Br J Cancer 1984;50:291-03.